Drug Shortage Report for SEPTRA INJECTION
Report ID | 129261 |
Drug Identification Number | 00550086 |
Brand name | SEPTRA INJECTION |
Common or Proper name | Septra Injection (sulfamethoxazole 80mg/mL - trimethoprim 16mg/mL (5mL/ampoule)) |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | TRIMETHOPRIM SULFAMETHOXAZOLE |
Strength(s) | 16MG 80MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 Ampoule |
ATC code | J01EE |
ATC description | SULFONAMIDES AND TRIMETHOPRIM |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-12-02 |
Estimated end date | 2020-12-16 |
Actual end date | 2020-12-22 |
Shortage status | Resolved |
Updated date | 2020-12-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-12-22 | French | Compare |
v4 | 2020-12-22 | English | Compare |
v3 | 2020-12-03 | English | Compare |
v2 | 2020-12-02 | French | Compare |
v1 | 2020-12-02 | English | Compare |
Showing 1 to 5 of 5